Please login to the form below

Not currently logged in
Email:
Password:

antibodies

This page shows the latest antibodies news and features for those working in and with pharma, biotech and healthcare.

China’s BeiGene takes PD-1 antibody into pivotal trials

China’s BeiGene takes PD-1 antibody into pivotal trials

China’ s BeiGene takes PD-1 antibody into pivotal trials. Firm aims to leapfrog immunotherapy leaders in huge market.

Latest news

  • Daily brief: Novartis spends big on ezcema, Daily brief: Novartis spends big on ezcema,

    Novartis eczema deal worth up to $1bn for biotechs. MorphoSys and Galapagos have signed a major new deal with Novartis on their atopic dermatitis candidate MOR106, an IL-17c antibody. ... This will allow it to fund development of its anti-CD19 antibody,

  • MaxCyte gets green light for solid tumour cell therapy MaxCyte gets green light for solid tumour cell therapy

    Mesothelin is expressed at elevated levels by a number of cancer types, including prostate and bile duct cancer, and  has also been targeted by antibody-based drugs such as Morphotek’s

  • Healthcare Comms news

    The annual event is open globally to emerging and established producers of film, TV and digital media, and this year Random42 entered its ‘short’, titled BiTE antibodies. ... The work, which was for US biopharma Amgen, told the story of the impact of

  • NHS England says yes to Roche's Hemlibra NHS England says yes to Roche's Hemlibra

    The drug gained European approval in February this year for haemophilia A patients with inhibitors, antibodies which mean patients no longer respond to standard Factor VIII therapy.

  • Biogen and Eisai claim mid-stage win for Alzheimer’s drug Biogen and Eisai claim mid-stage win for Alzheimer’s drug

    antibody for 18 months and, according to analysts at Jefferies, should prompt a phase III registration trial. ... This is the first late-stage anti-amyloid antibody study to successfully achieve statistically significant results at 18 months, further

More from news
Approximately 18 fully matching, plus 904 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare

    She works mainly in the translational field, focusing on the design and construction of antibody-based therapeutics to hit specific cancer targets. ... Current projects include developing antibodies for use as cancer imaging agents, antibody drug

  • Leo has its eyes on the prize Leo has its eyes on the prize

    Its landmark partnership with AstraZeneca and the launch of Kyntheum, the fully-human monoclonal antibody targeting psoriasis, and the phase III hope of tralokinumab for atopic dermatitis are part of an

  • Deal Watch January 2018

    Licence. 217. Teva Pharmaceuticals/ Alder Biopharmaceuticals. Patents covering anti-calcitonin gene-related peptide (CGRP) antibodies and methods - eptinezumab (p3). † ... licence agreement in January with respect to calcitonin gene-related peptide

  • The good, the bad and the ugly The good, the bad and the ugly

    Three CGRP monoclonal antibodies will launch in the US for migraine in 2018 - with a fourth anticipated in 2019.

  • The tipping point The tipping point

    For example, since 2015, when the first monoclonal antibody biosimilar, infliximab, was launched in Europe we have seen a notable increase in the overall use of infliximab. ... For example, providing therapeutic drug monitoring (TDM) to minimise loss of

More from intelligence
Approximately 1 fully matching, plus 94 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics